Cargando…
Tunable Drug Release from Fused Deposition Modelling (FDM) 3D-Printed Tablets Fabricated Using a Novel Extrudable Polymer
Three-dimensional (3D) printing is proving to be a pivotal technology for developing personalized dosage forms with bench to bedside feasibility. Fused deposition modelling (FDM) 3D printing has emerged as the most used technique wherein molten drug-loaded polymer filaments are deposited layer-by-la...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611745/ https://www.ncbi.nlm.nih.gov/pubmed/36297626 http://dx.doi.org/10.3390/pharmaceutics14102192 |
_version_ | 1784819605000159232 |
---|---|
author | Raje, Vishvesh Palekar, Siddhant Banella, Sabrina Patel, Ketan |
author_facet | Raje, Vishvesh Palekar, Siddhant Banella, Sabrina Patel, Ketan |
author_sort | Raje, Vishvesh |
collection | PubMed |
description | Three-dimensional (3D) printing is proving to be a pivotal technology for developing personalized dosage forms with bench to bedside feasibility. Fused deposition modelling (FDM) 3D printing has emerged as the most used technique wherein molten drug-loaded polymer filaments are deposited layer-by-layer to fabricate a predefined shape and internal geometry. However, for precise FDM 3D printing, it is imperative for the filaments to have peculiar mechanical/physicochemical properties, which the majority of the FDA/GRAS approved polymers lack. In the current study, a novel water-soluble polymer, Poly(2-ethyl-tetra-oxazoline) [PETOx] has been investigated as an extrudable and printable polymer with two different types of drug molecule—dextromethorphan hydrobromide (DXM) and hydrochlorothiazide (HCTZ). Hot-stage microscopy experiments of drug:polymer (1:1 w/w) and filaments were carried out at 25–275 °C. HCTZ-loaded filament showed higher toughness of 17 ± 3.25 × 10(6) J/m(3) compared with DXM and drug-free filament. Moisture sorption and flexural analysis was performed to understand the correlation of mechanical properties and storage humidity to printability. Varying the number of outer perimeters of each layer (shell number) was observed to affect the drug release pattern from the printlets. The DXM one-shell printlet showed >80%, whereas the DXM five-shell printlet showed >60% of the drug release within 60 min. PETOx could prove to be a high-performance and versatile 3D printable polymer. |
format | Online Article Text |
id | pubmed-9611745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96117452022-10-28 Tunable Drug Release from Fused Deposition Modelling (FDM) 3D-Printed Tablets Fabricated Using a Novel Extrudable Polymer Raje, Vishvesh Palekar, Siddhant Banella, Sabrina Patel, Ketan Pharmaceutics Article Three-dimensional (3D) printing is proving to be a pivotal technology for developing personalized dosage forms with bench to bedside feasibility. Fused deposition modelling (FDM) 3D printing has emerged as the most used technique wherein molten drug-loaded polymer filaments are deposited layer-by-layer to fabricate a predefined shape and internal geometry. However, for precise FDM 3D printing, it is imperative for the filaments to have peculiar mechanical/physicochemical properties, which the majority of the FDA/GRAS approved polymers lack. In the current study, a novel water-soluble polymer, Poly(2-ethyl-tetra-oxazoline) [PETOx] has been investigated as an extrudable and printable polymer with two different types of drug molecule—dextromethorphan hydrobromide (DXM) and hydrochlorothiazide (HCTZ). Hot-stage microscopy experiments of drug:polymer (1:1 w/w) and filaments were carried out at 25–275 °C. HCTZ-loaded filament showed higher toughness of 17 ± 3.25 × 10(6) J/m(3) compared with DXM and drug-free filament. Moisture sorption and flexural analysis was performed to understand the correlation of mechanical properties and storage humidity to printability. Varying the number of outer perimeters of each layer (shell number) was observed to affect the drug release pattern from the printlets. The DXM one-shell printlet showed >80%, whereas the DXM five-shell printlet showed >60% of the drug release within 60 min. PETOx could prove to be a high-performance and versatile 3D printable polymer. MDPI 2022-10-14 /pmc/articles/PMC9611745/ /pubmed/36297626 http://dx.doi.org/10.3390/pharmaceutics14102192 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Raje, Vishvesh Palekar, Siddhant Banella, Sabrina Patel, Ketan Tunable Drug Release from Fused Deposition Modelling (FDM) 3D-Printed Tablets Fabricated Using a Novel Extrudable Polymer |
title | Tunable Drug Release from Fused Deposition Modelling (FDM) 3D-Printed Tablets Fabricated Using a Novel Extrudable Polymer |
title_full | Tunable Drug Release from Fused Deposition Modelling (FDM) 3D-Printed Tablets Fabricated Using a Novel Extrudable Polymer |
title_fullStr | Tunable Drug Release from Fused Deposition Modelling (FDM) 3D-Printed Tablets Fabricated Using a Novel Extrudable Polymer |
title_full_unstemmed | Tunable Drug Release from Fused Deposition Modelling (FDM) 3D-Printed Tablets Fabricated Using a Novel Extrudable Polymer |
title_short | Tunable Drug Release from Fused Deposition Modelling (FDM) 3D-Printed Tablets Fabricated Using a Novel Extrudable Polymer |
title_sort | tunable drug release from fused deposition modelling (fdm) 3d-printed tablets fabricated using a novel extrudable polymer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611745/ https://www.ncbi.nlm.nih.gov/pubmed/36297626 http://dx.doi.org/10.3390/pharmaceutics14102192 |
work_keys_str_mv | AT rajevishvesh tunabledrugreleasefromfuseddepositionmodellingfdm3dprintedtabletsfabricatedusinganovelextrudablepolymer AT palekarsiddhant tunabledrugreleasefromfuseddepositionmodellingfdm3dprintedtabletsfabricatedusinganovelextrudablepolymer AT banellasabrina tunabledrugreleasefromfuseddepositionmodellingfdm3dprintedtabletsfabricatedusinganovelextrudablepolymer AT patelketan tunabledrugreleasefromfuseddepositionmodellingfdm3dprintedtabletsfabricatedusinganovelextrudablepolymer |